Overview and Scope
A lateral flow assay (LFA) is made up of four parts: a sample pad where the sample is dropped, a conjugate pad where labelled tags and biorecognition elements are combined, a reaction membrane with test and control lines for target antigen-antibody interaction, and an absorbent pad where waste is stored.
Sizing and Forecast
The lateral flow assays market size has grown strongly in recent years. It will grow from $11.25 billion in 2023 to $12.01 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to diagnostic advancements, rise in infectious diseases, application in pregnancy testing, growth in home healthcare, development of immunochromatography, point-of-care testing expansion.
The lateral flow assays market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expanding applications in disease detection, adoption in home testing kits, expansion in veterinary diagnostics, development of multiplex assays, rise in food and environmental testing. Major trends in the forecast period include personalized medicine and home testing, advancements in manufacturing techniques, environmental and food safety testing, focus on cost-effectiveness, application in drug and biomarker detection.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report
Segmentation & Regional Insights
The lateral flow assays market covered in this report is segmented –
1) By Type: Kits And Reagents, Lateral Flow Readers
2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays
3) By Application: Veterinary Diagnostics, Clinical/Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users
North America was the largest region in the lateral flow assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp
Major Driver Impacting Market Growth
The high prevalence of infectious diseases across the globe significantly contributes to the growth of the lateral flow assay market. In developing countries, the high frequency of infectious diseases such as HIV and malaria, combined with the inadequate healthcare system and rising public awareness, is projected to accelerate the adoption of lateral flow assay testing. The recent COVID-19 pandemic has highlighted the need for early illness detection capabilities, projected to fuel market expansion. According to the World Health Organization (WHO), in 2021, an estimated 10.6 million people were infected with tuberculosis globally, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost lives due to it. Therefore, the high prevalence of infectious diseases across the globe will contribute to the growth of the lateral flow assay market.
Key Industry Players
Major companies operating in the lateral flow assays market report are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., Alere Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Novus Biologicals Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., St. Croix Biosciences Inc., V-Chek Diagnostics
The lateral flow assays market report table of contents includes:
1. Executive Summary
2. Lateral Flow Assays Market Characteristics
3. Lateral Flow Assays Market Trends And Strategies
4. Lateral Flow Assays Market – Macro Economic Scenario
5. Global Lateral Flow Assays Market Size and Growth
……………..
32. Global Lateral Flow Assays Market Competitive Benchmarking
33. Global Lateral Flow Assays Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Lateral Flow Assays Market
35. Lateral Flow Assays Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/global-fructose-market-outlook/
https://topprnews.com/global-fruit-pulp-market-report/
https://topprnews.com/fuel-ethanol-market-growth/
https://goodprnews.com/global-fructose-market-report/
https://goodprnews.com/global-fruit-pulp-market-share/
https://goodprnews.com/fuel-ethanol-market-driver/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
